Literature DB >> 32281046

Highly aggressive thoracic desmoid tumors in adolescent siblings with fatal outcomes in an FAP kindred: a need for increased vigilance and intervention in at-risk AYAs.

Mohamed M Gad1, Anne-Marie Langevin2, Aaron J Sugalski2, Gail E Tomlinson3,4.   

Abstract

Desmoid tumors are a manifestation of familial adenomatous polyposis (FAP), associated with mutation of the APC gene. Although considered benign tumors, desmoids can be aggressive and cause considerable morbidity. Known risk factors for desmoid tumor growth include location of mutations within the APC gene, family history of desmoid tumors, previous surgery, female gender, and pregnancy. Desmoids occur at diverse sites, commonly within the abdomen or at sites of previous surgery; thoracic desmoids are relatively uncommon. Reported here is a highly desmoid tumor-prone FAP family with a truncating mutation in the APC gene at codon 1550 (c.4648G>T) in which female siblings developed remarkably similar thoracic desmoids with highly aggressive tumor behavior during the onset of puberty, throughout adolescence, and in one sibling during and following pregnancy. Both siblings had a fatal outcome. This case underscores the potential for aggressive behavior of desmoids during adolescence and the need for close vigilance during the adolescent and young adult (AYA) age range in desmoid-prone FAP kindreds.

Entities:  

Keywords:  Adolescence; Desmoid; FAP; Familial adenomatous polyposis

Mesh:

Year:  2020        PMID: 32281046      PMCID: PMC8098859          DOI: 10.1007/s10689-020-00177-2

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  10 in total

Review 1.  ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Authors:  Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt
Journal:  Am J Gastroenterol       Date:  2015-02-03       Impact factor: 10.864

Review 2.  Anti-oestrogen therapy in the treatment of desmoid tumours: a systematic review.

Authors:  D Bocale; M T Rotelli; A Cavallini; D F Altomare
Journal:  Colorectal Dis       Date:  2011-12       Impact factor: 3.788

3.  Risk factors predicting desmoid occurrence in patients with familial adenomatous polyposis: a meta-analysis.

Authors:  A Sinha; P P Tekkis; D C Gibbons; R K Phillips; S K Clark
Journal:  Colorectal Dis       Date:  2010-06-02       Impact factor: 3.788

4.  Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study.

Authors:  Maud Toulmonde; Marina Pulido; Isabelle Ray-Coquard; Thierry Andre; Nicolas Isambert; Christine Chevreau; Nicolas Penel; Emmanuelle Bompas; Esma Saada; François Bertucci; Celeste Lebbe; Axel Le Cesne; Patrick Soulie; Sophie Piperno-Neumann; Stephen Sweet; Fabiola Cecchi; Todd Hembrough; Carine Bellera; Michèle Kind; Amandine Crombe; Carlo Lucchesi; François Le Loarer; Jean-Yves Blay; Antoine Italiano
Journal:  Lancet Oncol       Date:  2019-07-19       Impact factor: 41.316

5.  Comparison of sporadic and FAP-associated desmoid-type fibromatoses.

Authors:  Laura Koskenvuo; Ari Ristimäki; Anna Lepistö
Journal:  J Surg Oncol       Date:  2017-06-01       Impact factor: 3.454

Review 6.  Desmoid-Type Fibromatosis: Who, When, and How to Treat.

Authors:  Javier Martínez Trufero; Isabel Pajares Bernad; Irene Torres Ramón; Jorge Hernando Cubero; Roberto Pazo Cid
Journal:  Curr Treat Options Oncol       Date:  2017-05

7.  Desmoid tumors: clinical features and outcome of an unpredictable and challenging manifestation of familial adenomatous polyposis.

Authors:  Fábio Guilherme Campos; Carlos Augusto Real Martinez; Marleny Novaes; Sérgio Carlos Nahas; Ivan Cecconello
Journal:  Fam Cancer       Date:  2015-06       Impact factor: 2.375

8.  Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk.

Authors:  Marco Fiore; Sara Coppola; Amanda J Cannell; Chiara Colombo; Monica M Bertagnolli; Suzanne George; Axel Le Cesne; Rebecca A Gladdy; Paolo G Casali; Carol J Swallow; Alessandro Gronchi; Sylvie Bonvalot; Chandrajit P Raut
Journal:  Ann Surg       Date:  2014-05       Impact factor: 12.969

9.  Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444.

Authors:  R Caspari; S Olschwang; W Friedl; M Mandl; C Boisson; T Böker; A Augustin; M Kadmon; G Möslein; G Thomas
Journal:  Hum Mol Genet       Date:  1995-03       Impact factor: 6.150

Review 10.  Familial adenomatous polyposis.

Authors:  Elizabeth Half; Dani Bercovich; Paul Rozen
Journal:  Orphanet J Rare Dis       Date:  2009-10-12       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.